Skip to main content
OpenTrials
Completed

NCT Number: NCT05585853

The Effect of Virtual Reality Glasses on Pain Level and Hemo-Dynamic Variables After Open Heart Surgery

In this study, between 1 January 2025 - 1 June 2025, who met the inclusion and exclusion criteria, a total of 82 patients who are on the 2nd or 3rd day after the surgery and who are hospitalized in the cardiovascular surgery intensive care clinic will be recruited.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Pain Hemodynamic Instability Neurologic Manifestations Pathological Conditions, Signs and Symptoms Signs and Symptoms

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Turkey, Mersin University,

Mersin, Turkey, 33343, Turkey (Türkiye)

About this study

The patient will be put on virtual reality glasses five minutes before the chest tube is removed. Afterwards, it will continue to be watched while the tube is taken and virtual reality glasses will be watched for another five minutes. Pain level and hemodynamic variables will be checked before, during, and 15 and 30 minutes after virtual reality glasses are watched. The participants in the control group will receive routine treatment and care, and their data will be collected at the same time as those in the study group. Hemodynamic variables will be monitored and recorded on the monitor.

Virtual reality glasses application is a method without any side effects. During the research, any adverse condition (vision problem, nausea, dizziness, etc.) related to the use of virtual glasses will be observed by the researcher. Since virtual reality glasses will be used in another patient after being used on one patient, disinfection will be made in line with the company's recommendations, taking into account the pandemic conditions. Throughout the application, feedback will be received from the patients by the researchers.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Agreeing to participate in the research (signing the Informed Consent Form),
  • Conscious and cooperative,
  • Stable hemodynamic status,
  • Speaks and understands Turkish,
  • Over 18 years old,
  • On the 2nd and 3rd day after open heart surgery,
  • Having chest tube,
  • No sensitivity or trauma in the area (for the study group) where the virtual reality glasses will be applied,
  • No active COVID-19 infection,
  • Patients without any psychiatric diagnosis

Exclusion criteria

  • Agreeing to participate in the research (signing the Informed Consent Form),
  • Not conscious,
  • Not cooperative
  • Unstable hemodynamic status,
  • Speaks and understands Turkish,
  • who are under the age of 18,
  • On the 0th or 1st day after surgery,
  • No chest tube,
  • Has sensitivity or trauma in the area (for the study group) where the virtual reality
  • Active COVID-19 infection,
  • Patients with a psychiatric diagnosis

Treatment and study plan

Virtual Reality

Other

Virtual reality glasses application is a method without any side effects. Patients will be treated for an average of 10 minutes. Data will be collected before, during, immediately after the application, at the 15th and 30th minutes.

Primary outcomes

  1. Pain evaluated using the Visual Analogue Scale

    Time frame: Change from before implementation up to 30 minutes

    Visual Analogue Scala has been developed to convert some values that cannot be measured numerically into numeric values. The VAS, which is a safe and easily applicable scale tool generally accepted in the world literature, consists of a 10 cm long line and there are subjective descriptive expressions at both ends of the scale (0 cm = none at all and 10 cm = highest degree.)

Secondary outcomes

  1. Systolic blood pressure

    Time frame: Change from before implementation up to 30 minutes

    Systolic blood pressure (SBP), mmHg

  2. Diastolic blood pressure

    Time frame: Change from before implementation up to 30 minutes

    Diastolic blood pressure (DBP), mmHg

  3. Heart rate

    Time frame: Change from before implementation up to 30 minutes

    Beats per minute

  4. Respiratory rate

    Time frame: Change from before implementation up to 30 minutes

    Lung breathing

  5. Peripheral oxygen saturation

    Time frame: Change from before implementation up to 30 minutes

    %, percentage of oxygenated hemoglobin in peripheral arterial blood

Sponsors and collaborators

Lead sponsor

Mersin University

Other

Registry information

Official study title

The Effect of Virtual Reality Glasses Applied on Chest Tube Removal After Open Heart Surgery on Pain Level and Hemodynamic Variables

Acronym: Virtual

Important dates

Study start
2025
Primary completion
2025
Study completion
2025
First posted
Oct 19, 2022
Registry last updated
Sep 23, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.